Streamlining drug discovery assays for cardiovascular disease using zebrafish

References

• Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357:2001–2015.
   PubMed Web of Science ®Google Scholar
• Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361:1045–1057.
   PubMed Web of Science ®Google Scholar
• McMurray JJ, Packer M, Desai AS, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371:993–1004.
   PubMed Web of Science ®Google Scholar
• Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373:2117–2128.
   PubMed Web of Science ®Google Scholar
• Wang X, Raghavan A, Chen T, et al. CRISPR-Cas9 targeting of PCSK9 in human hepatocytes in vivo-brief report. Arterioscler Thromb Vasc Biol. 2016;36:783–786.
   PubMed Web of Science ®Google Scholar
• Moretti A, Bellin M, Welling A, et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med. 2010;363:1397–1409.
   PubMed Web of Science ®Google Scholar
• Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442.
   PubMed Web of Science ®Google Scholar
• Fuster V, Kelly BB, Vedanthan R. Promoting global cardiovascular health: moving forward. Circulation. 2011;123:1671–1678.
   PubMed Web of Science ®Google Scholar
• Fuster V. Global burden of cardiovascular disease: time to implement feasible strategies and to monitor results. J Am Coll Cardiol. 2014;64:520–522.
   PubMed Web of Science ®Google Scholar
• Sacks LV, Shamsuddin HH, Yasinskaya YI, et al. Scientific and regulatory reasons for delay and denial of FDA approval of initial applications for new drugs, 2000-2012. JAMA. 2014;311:378–384.
   PubMed Web of Science ®Google Scholar
• Pammolli F, Magazzini L, Riccaboni M. The productivity crisis in pharmaceutical R&D. Nat Rev Drug Discov. 2011;10:428–438.
   PubMed Web of Science ®Google Scholar
• Hughes JP, Rees S, Kalindjian SB, et al. Principles of early drug discovery. Br J Pharmacol. 2011;162:1239–1249.
   PubMed Web of Science ®Google Scholar
• Everett JR. Academic drug discovery: current status and prospects. Expert Opin Drug Discov. 2015;10:937–944.
   PubMed Web of Science ®Google Scholar
• Pott A, Rottbauer W, Just S. Functional genomics in zebrafish as a tool to identify novel antiarrhythmic targets. Curr Med Chem. 2014;21:1320–1329.
   PubMed Web of Science ®Google Scholar
• MacRae CA, Peterson RT. Zebrafish-based small molecule discovery. Chem Biol. 2003;10:901–908.
   PubMed Web of Science ®Google Scholar
• Pott A, Shahid M, Kohler D, et al. Therapeutic chemical screen identifies phosphatase inhibitors to reconstitute PKB phosphorylation and cardiac contractility in ILK-deficient zebrafish. Biomolecules. 2018;8. DOI:10.3390/biom8040153.
   Web of Science ®Google Scholar
• Kramer F, Just S, Zeller T. New perspectives: systems medicine in cardiovascular disease. BMC Syst Biol. 2018;12: 57-018-0579-5.
   PubMed Web of Science ®Google Scholar
• Kessler M, Rottbauer W, Just S. Recent progress in the use of zebrafish for novel cardiac drug discovery. Expert Opin Drug Discov. 2015;10:1231–1241.
   PubMed Web of Science ®Google Scholar
• Stainier DY. Zebrafish genetics and vertebrate heart formation. Nat Rev Genet. 2001;2:39–48. **.
   PubMed Web of Science ®Google Scholar
• Paone C, Diofano F, Park DD, et al. Genetics of cardiovascular disease: fishing for causality. Front Cardiovasc Med. 2018;5:60.
   PubMed Web of Science ®Google Scholar
• Hu N, Yost HJ, Clark EB. Cardiac morphology and blood pressure in the adult zebrafish. Anat Rec. 2001;264:1–12.
   PubMedGoogle Scholar
• Bakkers J. Zebrafish as a model to study cardiac development and human cardiac disease. Cardiovasc Res. 2011;91:279–288.
   PubMed Web of Science ®Google Scholar
• Giardoglou P, Beis D. On zebrafish disease models and matters of the heart. Biomedicines. 2019;7. DOI:10.3390/biomedicines7010015
   Web of Science ®Google Scholar
• Brown DR, Samsa LA, Qian L, et al. Advances in the study of heart development and disease using zebrafish. J Cardiovasc Dev Dis. 2016;3:13. Epub 2016 Apr 9.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration, HHS. International conference on harmonisation; guidance on S7B nonclinical evaluation of the potential for delayed ventricular repolarization (QT Interval Prolongation) by human pharmaceuticals; availability. Notice Fed Regist. 2005; 70:61133–61134.
   PubMedGoogle Scholar
• van Opbergen CJM, Koopman CD, Kok BJM, et al. Optogenetic sensors in the zebrafish heart: a novel in vivo electrophysiological tool to study cardiac arrhythmogenesis. Theranostics. 2018;8:4750–4764.
   PubMed Web of Science ®Google Scholar
• Hoage T, Ding Y, Xu X. Quantifying cardiac functions in embryonic and adult zebrafish. Methods Mol Biol. 2012;843:11–20.
   PubMedGoogle Scholar
• Ritter JM. Cardiac safety, drug-induced QT prolongation and torsade de pointes (TdP). Br J Clin Pharmacol. 2012;73:331–334.
   PubMed Web of Science ®Google Scholar
• Gromo G, Mann J, Fitzgerald JD. Cardiovascular drug discovery: a perspective from a research-based pharmaceutical company. Cold Spring Harb Perspect Med. 2014;4. DOI:10.1101/cshperspect.a014092
   Web of Science ®Google Scholar
• Kithcart A, MacRae CA. Using zebrafish for high-throughput screening of novel cardiovascular drugs. JACC Basic Transl Sci. 2017;2:1–12. **.
   PubMedGoogle Scholar
• Kithcart AP, MacRae CA. Zebrafish assay development for cardiovascular disease mechanism and drug discovery. Prog Biophys Mol Biol. 2018;138:126–131.
   PubMed Web of Science ®Google Scholar
• Cianciolo Cosentino C, Roman BL, Drummond IA, et al. Intravenous microinjections of zebrafish larvae to study acute kidney injury. J Vis Exp. 2010;42:pii: 2079.
   Google Scholar
• Li Y, Chen T, Miao X, et al. Zebrafish: A promising in vivo model for assessing the delivery of natural products, fluorescence dyes and drugs across the blood-brain barrier. Pharmacol Res. 2017;125:246–257.
   PubMed Web of Science ®Google Scholar
• Howe K, Clark MD, Torroja CF, et al. The zebrafish reference genome sequence and its relationship to the human genome. Nature. 2013;496:498–503.
   PubMed Web of Science ®Google Scholar
• de Souza Anselmo C, Sardela VF, de Sousa VP, et al. Zebrafish (Danio rerio): a valuable tool for predicting the metabolism of xenobiotics in humans? Comp Biochem Physiol C Toxicol Pharmacol. 2018;212:34–46.
   PubMed Web of Science ®Google Scholar
• McGrath P, Li CQ. Zebrafish: a predictive model for assessing drug-induced toxicity. Drug Discov Today. 2008;13:394–401.
   PubMed Web of Science ®Google Scholar
• Goldstone JV, McArthur AG, Kubota A, et al. Identification and developmental expression of the full complement of Cytochrome P450 genes in Zebrafish. BMC Genomics. 2010;11: 643–664.
   PubMed Web of Science ®Google Scholar
• Dahme T, Katus HA, Rottbauer W. Fishing for the genetic basis of cardiovascular disease. Dis Model Mech. 2009;2:18–22.
   PubMed Web of Science ®Google Scholar
• Staudt D, Stainier D. Uncovering the molecular and cellular mechanisms of heart development using the zebrafish. Annu Rev Genet. 2012;46:397–418.
   PubMed Web of Science ®Google Scholar
• Stainier DY, Fishman MC. The zebrafish as a model system to study cardiovascular development. Trends Cardiovasc Med. 1994;4:207–212.
   PubMed Web of Science ®Google Scholar
• Iwamatsu T. Stages of normal development in the medaka Oryzias latipes. Mech Dev. 2004;121:605–618.
   PubMed Web of Science ®Google Scholar
• Furutani-Seiki M, Wittbrodt J. Medaka and zebrafish, an evolutionary twin study. Mech Dev. 2004;121:629–637.
   PubMed Web of Science ®Google Scholar
• Vogel B, Meder B, Just S, et al. In-vivo characterization of human dilated cardiomyopathy genes in zebrafish. Biochem Biophys Res Commun. 2009;390:516–522.
   PubMed Web of Science ®Google Scholar
• Kustermann M, Manta L, Paone C, et al. Loss of the novel Vcp (valosin containing protein) interactor Washc4 interferes with autophagy-mediated proteostasis in striated muscle and leads to myopathy in vivo. Autophagy. 2018;14:1911–1927.
   PubMed Web of Science ®Google Scholar
• Buhrdel JB, Hirth S, Kessler M, et al. In vivo characterization of human myofibrillar myopathy genes in zebrafish. Biochem Biophys Res Commun. 2015;461:217–223.
   PubMed Web of Science ®Google Scholar
• Hein SJ, Lehmann LH, Kossack M, et al. Advanced echocardiography in adult zebrafish reveals delayed recovery of heart function after myocardial cryoinjury. PLoS One. 2015; 10:e0122665.
   PubMed Web of Science ®Google Scholar
• Huang CC, Monte A, Cook JM, et al. Zebrafish heart failure models for the evaluation of chemical probes and drugs. Assay Drug Dev Technol. 2013;11:561–572.
   PubMed Web of Science ®Google Scholar
• Shi X, Verma S, Yun J, et al. Effect of empagliflozin on cardiac biomarkers in a zebrafish model of heart failure: clues to the EMPA-REG OUTCOME trial? Mol Cell Biochem. 2017;433:97–102.
   PubMed Web of Science ®Google Scholar
• Hou JH, Kralj JM, Douglass AD, et al. Simultaneous mapping of membrane voltage and calcium in zebrafish heart in vivo reveals chamber-specific developmental transitions in ionic currents. Front Physiol. 2014;5:344.
   PubMed Web of Science ®Google Scholar
• Schurgers E, Moorlag M, Hemker C, et al. Thrombin generation in zebrafish blood. PLoS One. 2016;11:e0149135.
   PubMed Web of Science ®Google Scholar
• Pott A, Bock S, Berger IM, et al. Mutation of the Na(+)/K(+)-ATPase Atp1a1a.1 causes QT interval prolongation and bradycardia in zebrafish. J Mol Cell Cardiol. 2018;120:42–52.
   PubMed Web of Science ®Google Scholar
• Lin MH, Chou HC, Chen YF, et al. Development of a rapid and economic in vivo electrocardiogram platform for cardiovascular drug assay and electrophysiology research in adult zebrafish. Sci Rep. 2018;8: 15986-018-33577-7.
   Web of Science ®Google Scholar
• Jagadeeswaran P, Sheehan JP. Analysis of blood coagulation in the zebrafish. Blood Cells Mol Dis. 1999;25:239–249.
   PubMed Web of Science ®Google Scholar
• Zhu XY, Liu HC, Guo SY, et al. A zebrafish thrombosis model for assessing antithrombotic drugs. Zebrafish. 2016;13:335–344.
   PubMed Web of Science ®Google Scholar
• Hanumanthaiah R, Thankavel B, Day K, et al. Developmental expression of vitamin K-dependent gamma-carboxylase activity in zebrafish embryos: effect of warfarin. Blood Cells Mol Dis. 2001;27:992–999.
   PubMed Web of Science ®Google Scholar
• Schier AF, Neuhauss SC, Harvey M, et al. Mutations affecting the development of the embryonic zebrafish brain. Development. 1996;123:165–178.
   PubMed Web of Science ®Google Scholar
• Stainier DY, Fouquet B, Chen JN, et al. Mutations affecting the formation and function of the cardiovascular system in the zebrafish embryo. Development. 1996;123:285–292.
   PubMed Web of Science ®Google Scholar
• Stainier DY, Fishman MC. Patterning the zebrafish heart tube: acquisition of anteroposterior polarity. Dev Biol. 1992;153:91–101.
   PubMed Web of Science ®Google Scholar
• Liu J, Stainier DY. Zebrafish in the study of early cardiac development. Circ Res. 2012;110:870–874.
   PubMed Web of Science ®Google Scholar
• Rottbauer W, Baker K, Wo ZG, et al. Growth and function of the embryonic heart depend upon the cardiac-specific L-type calcium channel alpha1 subunit. Dev Cell. 2001;1:265–275.
   PubMed Web of Science ®Google Scholar
• Hassel D, Dahme T, Erdmann J, et al. Nexilin mutations destabilize cardiac Z-disks and lead to dilated cardiomyopathy. Nat Med. 2009;15:1281–1288.
   PubMed Web of Science ®Google Scholar
• Hassel D, Scholz EP, Trano N, et al. Deficient zebrafish ether-a-go-go-related gene channel gating causes short-QT syndrome in zebrafish reggae mutants. Circulation. 2008;117:866–875.
   PubMed Web of Science ®Google Scholar
• Meder B, Laufer C, Hassel D, et al. A single serine in the carboxyl terminus of cardiac essential myosin light chain-1 controls cardiomyocyte contractility in vivo. Circ Res. 2009;104:650–659.
   PubMed Web of Science ®Google Scholar
• Kessler M, Kieltsch A, Kayvanpour E, et al. A zebrafish model for FHL1-opathy reveals loss-of-function effects of human FHL1 mutations. Neuromuscul Disord. 2018;28:521–531.
   PubMed Web of Science ®Google Scholar
• Milan DJ, Jones IL, Ellinor PT, et al. In vivo recording of adult zebrafish electrocardiogram and assessment of drug-induced QT prolongation. Am J Physiol Heart Circ Physiol. 2006;291:H269–73.
   PubMed Web of Science ®Google Scholar
• Cornet C, Di Donato V, Terriente J. Combining zebrafish and CRISPR/Cas9: toward a more efficient drug discovery pipeline. Front Pharmacol. 2018;9:703.
   PubMed Web of Science ®Google Scholar
• Dahlem TJ, Hoshijima K, Jurynec MJ, et al. Simple methods for generating and detecting locus-specific mutations induced with TALENs in the zebrafish genome. PLoS Genet. 2012;8:e1002861.
   PubMed Web of Science ®Google Scholar
• Pauli A, Montague TG, Lennox KA, et al. Antisense oligonucleotide-mediated transcript knockdown in zebrafish. PLoS One. 2015;10:e0139504.
   PubMed Web of Science ®Google Scholar
• Heasman J. Morpholino oligos: making sense of antisense?. Dev Biol. 2002;243:209–214.
   PubMed Web of Science ®Google Scholar
• Just S, Raphel L, Berger IM, et al. Tbx20 is an essential regulator of embryonic heart growth in zebrafish. PLoS One. 2016;11:e0167306.
   PubMed Web of Science ®Google Scholar
• Huttner IG, Wang LW, Santiago CF, et al. A-band titin truncation in zebrafish causes dilated cardiomyopathy and hemodynamic stress intolerance. Circ Genom Precis Med. 2018;11:e002135.
   PubMed Web of Science ®Google Scholar
• Huang W, Zhang R, Xu X. Myofibrillogenesis in the developing zebrafish heart: a functional study of tnnt2. Dev Biol. 2009;331:237–249.
   PubMed Web of Science ®Google Scholar
• Watkins H, McKenna WJ, Thierfelder L, et al. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med. 1995;332:1058–1064.
   PubMed Web of Science ®Google Scholar
• Chen Z, Huang W, Dahme T, et al. Depletion of zebrafish essential and regulatory myosin light chains reduces cardiac function through distinct mechanisms. Cardiovasc Res. 2008;79:97–108.
   PubMed Web of Science ®Google Scholar
• Nagwekar J, Duggal D, Midde K, et al. A novel method of determining the functional effects of a minor genetic modification of a protein. Front Cardiovasc Med. 2015;2:35.
   PubMedGoogle Scholar
• Hernandez OM, Jones M, Guzman G, et al. Myosin essential light chain in health and disease. Am J Physiol Heart Circ Physiol. 2007;292:H1643–54.
   PubMed Web of Science ®Google Scholar
• Rottbauer W, Wessels G, Dahme T, et al. Cardiac myosin light chain-2: a novel essential component of thick-myofilament assembly and contractility of the heart. Circ Res. 2006;99:323–331.
   PubMed Web of Science ®Google Scholar
• Poetter K, Jiang H, Hassanzadeh S, et al. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet. 1996;13:63–69.
   PubMed Web of Science ®Google Scholar
• Ahn DG, Kourakis MJ, Rohde LA, et al. T-box gene tbx5 is essential for formation of the pectoral limb bud. Nature. 2002;417:754–758.
   PubMed Web of Science ®Google Scholar
• Basson CT, Bachinsky DR, Lin RC, et al. Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet. 1997;15:30–35.
   PubMed Web of Science ®Google Scholar
• Balijepalli SY, Anderson CL, Lin EC, et al. Rescue of mutated cardiac ion channels in inherited arrhythmia syndromes. J Cardiovasc Pharmacol. 2010;56:113–122.
   PubMed Web of Science ®Google Scholar
• Thomas D, Kiehn J, Katus HA, et al. Adrenergic regulation of the rapid component of the cardiac delayed rectifier potassium current, I(Kr), and the underlying hERG ion channel. Basic Res Cardiol. 2004;99:279–287.
   PubMed Web of Science ®Google Scholar
• Meder B, Scholz EP, Hassel D, et al. Reconstitution of defective protein trafficking rescues Long-QT syndrome in zebrafish. Biochem Biophys Res Commun. 2011;408:218–224.
   PubMed Web of Science ®Google Scholar
• Schimpf R, Wolpert C, Gaita F, et al. Short QT syndrome. Cardiovasc Res. 2005;67:357–366.
   PubMed Web of Science ®Google Scholar
• Splawski I, Timothy KW, Sharpe LM, et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell. 2004;119:19–31.
   PubMed Web of Science ®Google Scholar
• Wemhoner K, Friedrich C, Stallmeyer B, et al. Gain-of-function mutations in the calcium channel CACNA1C (Cav1.2) cause non-syndromic long-QT but not Timothy syndrome. J Mol Cell Cardiol. 2015;80:186–195.
   PubMed Web of Science ®Google Scholar
• Li W, Zheng NZ, Yuan Q, et al. NFAT5-mediated CACNA1C expression is critical for cardiac electrophysiological development and maturation. J Mol Med (Berl). 2016;94:993–1002.
   PubMed Web of Science ®Google Scholar
• Sztal TE, Zhao M, Williams C, et al. Zebrafish models for nemaline myopathy reveal a spectrum of nemaline bodies contributing to reduced muscle function. Acta Neuropathol. 2015;130:389–406.
   PubMed Web of Science ®Google Scholar
• Gatayama R, Ueno K, Nakamura H, et al. Nemaline myopathy with dilated cardiomyopathy in childhood. Pediatrics. 2013;131:e1986–90.
   PubMed Web of Science ®Google Scholar
• D’Amico A, Graziano C, Pacileo G, et al. Fatal hypertrophic cardiomyopathy and nemaline myopathy associated with ACTA1 K336E mutation. Neuromuscul Disord. 2006;16:548–552.
   PubMed Web of Science ®Google Scholar
• Hyde AS, Farmer EL, Easley KE, et al. UDP-glucose dehydrogenase polymorphisms from patients with congenital heart valve defects disrupt enzyme stability and quaternary assembly. J Biol Chem. 2012;287:32708–32716.
   PubMed Web of Science ®Google Scholar
• Fishman MC, Stainier DY. Cardiovascular development Prospects for a genetic approach. Circ Res. 1994;74:757–763.
   PubMed Web of Science ®Google Scholar
• Warren KS, Fishman MC. “Physiological genomics”: mutant screens in zebrafish. Am J Physiol. 1998;275:H1–7.
   PubMedGoogle Scholar
• Shore EM, Xu M, Feldman GJ, et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet. 2006;38:525–527.
   PubMed Web of Science ®Google Scholar
• LaBonty M, Pray N, Yelick PC. A zebrafish model of human fibrodysplasia ossificans progressiva. Zebrafish. 2017;14:293–304.
   PubMed Web of Science ®Google Scholar
• Masuelli L, Bei R, Sacchetti P, et al. Beta-catenin accumulates in intercalated disks of hypertrophic cardiomyopathic hearts. Cardiovasc Res. 2003;60:376–387.
   PubMed Web of Science ®Google Scholar
• Hurlstone AF, Haramis AP, Wienholds E, et al. The Wnt/beta-catenin pathway regulates cardiac valve formation. Nature. 2003;425:633–637.
   PubMed Web of Science ®Google Scholar
• YH S, Zhang Y, Ding Y, et al. Cardiac transcriptome and dilated cardiomyopathy genes in zebrafish. Circ Cardiovasc Genet. 2015;8:261–269.
   PubMedGoogle Scholar
• Tomita-Mitchell A, Stamm KD, Mahnke DK, et al. Impact of MYH6 variants in hypoplastic left heart syndrome. Physiol Genomics. 2016;48:912–921.
   PubMed Web of Science ®Google Scholar
• Mittal A, Sharma R, Prasad R, et al. Role of cardiac TBX20 in dilated cardiomyopathy. Mol Cell Biochem. 2016;414:129–136.
   PubMed Web of Science ®Google Scholar
• Singh MK, Christoffels VM, Dias JM, et al. Tbx20 is essential for cardiac chamber differentiation and repression of Tbx2. Development. 2005;132:2697–2707.
   PubMed Web of Science ®Google Scholar
• Zhao CM, Bing-Sun, Song HM, et al. TBX20 loss-of-function mutation associated with familial dilated cardiomyopathy. Clin Chem Lab Med. 2016;54:325–332.
   PubMed Web of Science ®Google Scholar
• Chakraborty S, Sengupta A, Yutzey KE. Tbx20 promotes cardiomyocyte proliferation and persistence of fetal characteristics in adult mouse hearts. J Mol Cell Cardiol. 2013;62:203–213.
   PubMed Web of Science ®Google Scholar
• Bendig G, Grimmler M, Huttner IG, et al. Integrin-linked kinase, a novel component of the cardiac mechanical stretch sensor, controls contractility in the zebrafish heart. Genes Dev. 2006;20:2361–2372.
   PubMed Web of Science ®Google Scholar
• Knoll R, Postel R, Wang J, et al. Laminin-alpha4 and integrin-linked kinase mutations cause human cardiomyopathy via simultaneous defects in cardiomyocytes and endothelial cells. Circulation. 2007;116:515–525.
   PubMed Web of Science ®Google Scholar
• Alcalai R, Seidman JG, Seidman CE. Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics. J Cardiovasc Electrophysiol. 2008;19:104–110.
   PubMed Web of Science ®Google Scholar
• Tardiff JC. Sarcomeric proteins and familial hypertrophic cardiomyopathy: linking mutations in structural proteins to complex cardiovascular phenotypes. Heart Fail Rev. 2005;10:237–248.
   PubMed Web of Science ®Google Scholar
• Zhao L, Zhao X, Tian T, et al. Heart-specific isoform of tropomyosin4 is essential for heartbeat in zebrafish embryos. Cardiovasc Res. 2008;80:200–208.
   PubMed Web of Science ®Google Scholar
• Xu X, Meiler SE, Zhong TP, et al. Cardiomyopathy in zebrafish due to mutation in an alternatively spliced exon of titin. Nat Genet. 2002;30:205–209.
   PubMed Web of Science ®Google Scholar
• Gigli M, Begay RL, Morea G, et al. A review of the giant protein titin in clinical molecular diagnostics of cardiomyopathies. Front Cardiovasc Med. 2016;3:21.
   PubMed Web of Science ®Google Scholar
• Herman DS, Lam L, Taylor MR, et al. Truncations of titin causing dilated cardiomyopathy. N Engl J Med. 2012;366:619–628.
   PubMed Web of Science ®Google Scholar
• Zou J, Tran D, Baalbaki M, et al. An internal promoter underlies the difference in disease severity between N- and C-terminal truncation mutations of Titin in zebrafish. Elife. 2015;4:e09406.
   PubMed Web of Science ®Google Scholar
• Tessadori F, van Weerd JH, Burkhard SB, et al. Identification and functional characterization of cardiac pacemaker cells in zebrafish. PLoS One. 2012;7:e47644.
   PubMed Web of Science ®Google Scholar
• Verkerk AO, Remme CA. Zebrafish: a novel research tool for cardiac (patho)electrophysiology and ion channel disorders. Front Physiol. 2012;3:255.
   PubMed Web of Science ®Google Scholar
• Langheinrich U, Vacun G, Wagner T. Zebrafish embryos express an orthologue of HERG and are sensitive toward a range of QT-prolonging drugs inducing severe arrhythmia. Toxicol Appl Pharmacol. 2003;193:370–382.
   PubMed Web of Science ®Google Scholar
• Schimpf R, Veltmann C, Wolpert C, et al. Channelopathies: brugada syndrome, long QT syndrome, short QT syndrome, and CPVT. Herz. 2009;34:281–288.
   PubMed Web of Science ®Google Scholar
• Schimpf R, Borggrefe M, Wolpert C. Clinical and molecular genetics of the short QT syndrome. Curr Opin Cardiol. 2008;23:192–198.
   PubMed Web of Science ®Google Scholar
• Pfeufer A, Sanna S, Arking DE, et al. Common variants at ten loci modulate the QT interval duration in the QTSCD Study. Nat Genet. 2009;41:407–414.
   PubMed Web of Science ®Google Scholar
• Skou JC. The influence of some cations on an adenosine triphosphatase from peripheral nerves. Biochim Biophys Acta. 1957;23:394–401.
   PubMed Web of Science ®Google Scholar
• Hu N, Sedmera D, Yost HJ, et al. Structure and function of the developing zebrafish heart. Anat Rec. 2000;260:148–157.
   PubMedGoogle Scholar
• Brette F, Luxan G, Cros C, et al. Characterization of isolated ventricular myocytes from adult zebrafish (Danio rerio). Biochem Biophys Res Commun. 2008;374:143–146.
   PubMed Web of Science ®Google Scholar
• Warren KS, Baker K, Fishman MC. The slow mo mutation reduces pacemaker current and heart rate in adult zebrafish. Am J Physiol Heart Circ Physiol. 2001;281:H1711–9.
   PubMed Web of Science ®Google Scholar
• Nemtsas P, Wettwer E, Christ T, et al. Adult zebrafish heart as a model for human heart? An electrophysiological study. J Mol Cell Cardiol. 2010;48:161–171.
   PubMed Web of Science ®Google Scholar
• Peterson RT, Shaw SY, Peterson TA, et al. Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation. Nat Biotechnol. 2004;22:595–599.
   PubMed Web of Science ®Google Scholar
• Hong CC, Peterson QP, Hong JY, et al. Artery/vein specification is governed by opposing phosphatidylinositol-3 kinase and MAP kinase/ERK signaling. Curr Biol. 2006;16:1366–1372.
   PubMed Web of Science ®Google Scholar
• Peal DS, Mills RW, Lynch SN, et al. Novel chemical suppressors of long QT syndrome identified by an in vivo functional screen. Circulation. 2011;123:23–30.
   PubMed Web of Science ®Google Scholar
• Burns CG, Milan DJ, Grande EJ, et al. High-throughput assay for small molecules that modulate zebrafish embryonic heart rate. Nat Chem Biol. 2005;1:263–264.
   PubMed Web of Science ®Google Scholar
• Yozzo KL, Isales GM, Raftery TD, et al. High-content screening assay for identification of chemicals impacting cardiovascular function in zebrafish embryos. Environ Sci Technol. 2013;47:11302–11310.
   PubMed Web of Science ®Google Scholar
• Lin KY, Chang WT, Lai YC, et al. Toward functional screening of cardioactive and cardiotoxic drugs with zebrafish in vivo using pseudodynamic three-dimensional imaging. Anal Chem. 2014;86:2213–2220.
   PubMed Web of Science ®Google Scholar
• Spomer W, Pfriem A, Alshut R, et al. High-throughput screening of zebrafish embryos using automated heart detection and imaging. J Lab Autom. 2012;17:435–442.
   PubMedGoogle Scholar
• Pylatiuk C, Sanchez D, Mikut R, et al. Automatic zebrafish heartbeat detection and analysis for zebrafish embryos. Zebrafish. 2014;11:379–383.
   PubMed Web of Science ®Google Scholar
• Breitwieser H, Dickmeis T, Vogt M, et al. Fully automated pipetting sorting system for different morphological phenotypes of zebrafish embryos. SLAS Technol. 2018;23:128–133.
   PubMed Web of Science ®Google Scholar
• Letamendia A, Quevedo C, Ibarbia I, et al. Development and validation of an automated high-throughput system for zebrafish in vivo screenings. PLoS One. 2012;7:e36690.
   PubMed Web of Science ®Google Scholar
• Wittbrodt JN, Liebel U, Gehrig J. Generation of orientation tools for automated zebrafish screening assays using desktop 3D printing. BMC Biotechnol. 2014;14: 36–42.
   PubMed Web of Science ®Google Scholar
• Gehrig J, Pandey G, Westhoff JH. Zebrafish as a model for drug screening in genetic kidney diseases. Front Pediatr. 2018;6:183.
   PubMed Web of Science ®Google Scholar
• Pandey G, Westhoff JH, Schaefer F, et al. A smart imaging workflow for organ-specific screening in a cystic kidney zebrafish disease model. Int J Mol Sci. 2019;20. DOI:10.3390/ijms20061290.
   Web of Science ®Google Scholar
• Schutera M, Dickmeis T, Mione M, et al. Automated phenotype pattern recognition of zebrafish for high-throughput screening. Bioengineered. 2016;7:261–265.
   PubMed Web of Science ®Google Scholar